Nutrien（0NHS）株式概要Nutrien Ltd.は農作物の投入資材とサービスを提供している。 詳細0NHS ファンダメンタル分析スノーフレーク・スコア評価6/6将来の成長0/6過去の実績4/6財務の健全性5/6配当金3/6報酬当社が推定した公正価値より32.4%で取引されている 過去1年間で収益は74.6%増加しました 同業他社や業界と比較して、良好な取引価格 アナリストらは、株価が21.6%上昇するだろうとほぼ一致している。 リスク分析今後3年間の収益は年平均3%減少すると予測されている。 多額の負債を抱えている すべてのリスクチェックを見る0NHS Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW479,227 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA479,227 investors already sharing narrativesYour Fair ValueUS$Current PriceUS$64.8732.4% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture035b2016201920222025202620282031Revenue US$27.4bEarnings US$2.4bAdvancedSet Fair ValueView all narrativesNutrien Ltd. 競合他社FresnilloSymbol: LSE:FRESMarket cap: UK£21.1bCroda InternationalSymbol: LSE:CRDAMarket cap: UK£4.6bAntofagastaSymbol: LSE:ANTOMarket cap: UK£39.2bGlencoreSymbol: LSE:GLENMarket cap: UK£65.4b価格と性能株価の高値、安値、推移の概要Nutrien過去の株価現在の株価CA$64.8752週高値CA$87.3652週安値CA$53.05ベータ1.061ヶ月の変化-0.29%3ヶ月変化-9.32%1年変化17.16%3年間の変化-2.58%5年間の変化2.42%IPOからの変化19.60%最新ニュースReported Earnings • Aug 07Second quarter 2026 earnings released: EPS: US$2.53 (vs US$2.51 in 2Q 2025)Second quarter 2026 results: EPS: US$2.53. Revenue: US$10.6b (up 4.0% from 2Q 2025). Net income: US$1.21b (flat on 2Q 2025). Profit margin: 11% (in line with 2Q 2025). Revenue is forecast to stay flat during the next 3 years compared to a 11% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Aug 06Nutrien Ltd. Provides Operating Guidance for the Fiscal Year 2026Nutrien Ltd. provided operating guidance for the fiscal year 2026. For the year, the company expects Potash sales volume guidance was increased to 14.2 million to 14.8 million tonnes due to strong demand in key offshore markets and is consistent with global shipment expectation. Nitrogen sales volume guidance of 9.2 million to 9.7 million tonnes is supported by planned reliability improvements and debottlenecking initiatives. The range reflects the completion of planned turnarounds in the third quarter of 2026 and higher ammonia operating rates in the fourth quarter compared to the prior year. Phosphate sales volume guidance of 2.4 million to 2.6 million tonnes reflects the benefits of reliability improvement initiatives completed in 2025.お知らせ • Jul 23Nutrien Ltd. to Report Q4, 2026 Results on Feb 18, 2027Nutrien Ltd. announced that they will report Q4, 2026 results on Feb 18, 2027Buy Or Sell Opportunity • Jul 15Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.5% to US$67.19. The fair value is estimated to be US$84.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has declined by 37%. For the next 3 years, revenue is forecast to grow by 0.2% per annum. Earnings are forecast to decline by 6.7% per annum over the same time period.Upcoming Dividend • Jun 23Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 30 June 2026. Payment date: 17 July 2026. Payout ratio is a comfortable 44% and this is well supported by cash flows. Trailing yield: 3.5%. Lower than top quartile of British dividend payers (5.6%). In line with average of industry peers (3.7%).Buy Or Sell Opportunity • Jun 05Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 13% to US$67.38. The fair value is estimated to be US$85.61, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has declined by 37%. For the next 3 years, revenue is forecast to grow by 0.3% per annum. Earnings are forecast to decline by 6.9% per annum over the same time period.最新情報をもっと見るRecent updatesReported Earnings • Aug 07Second quarter 2026 earnings released: EPS: US$2.53 (vs US$2.51 in 2Q 2025)Second quarter 2026 results: EPS: US$2.53. Revenue: US$10.6b (up 4.0% from 2Q 2025). Net income: US$1.21b (flat on 2Q 2025). Profit margin: 11% (in line with 2Q 2025). Revenue is forecast to stay flat during the next 3 years compared to a 11% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Aug 06Nutrien Ltd. Provides Operating Guidance for the Fiscal Year 2026Nutrien Ltd. provided operating guidance for the fiscal year 2026. For the year, the company expects Potash sales volume guidance was increased to 14.2 million to 14.8 million tonnes due to strong demand in key offshore markets and is consistent with global shipment expectation. Nitrogen sales volume guidance of 9.2 million to 9.7 million tonnes is supported by planned reliability improvements and debottlenecking initiatives. The range reflects the completion of planned turnarounds in the third quarter of 2026 and higher ammonia operating rates in the fourth quarter compared to the prior year. Phosphate sales volume guidance of 2.4 million to 2.6 million tonnes reflects the benefits of reliability improvement initiatives completed in 2025.お知らせ • Jul 23Nutrien Ltd. to Report Q4, 2026 Results on Feb 18, 2027Nutrien Ltd. announced that they will report Q4, 2026 results on Feb 18, 2027Buy Or Sell Opportunity • Jul 15Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.5% to US$67.19. The fair value is estimated to be US$84.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has declined by 37%. For the next 3 years, revenue is forecast to grow by 0.2% per annum. Earnings are forecast to decline by 6.7% per annum over the same time period.Upcoming Dividend • Jun 23Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 30 June 2026. Payment date: 17 July 2026. Payout ratio is a comfortable 44% and this is well supported by cash flows. Trailing yield: 3.5%. Lower than top quartile of British dividend payers (5.6%). In line with average of industry peers (3.7%).Buy Or Sell Opportunity • Jun 05Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 13% to US$67.38. The fair value is estimated to be US$85.61, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has declined by 37%. For the next 3 years, revenue is forecast to grow by 0.3% per annum. Earnings are forecast to decline by 6.9% per annum over the same time period.Declared Dividend • May 13First quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 30th June 2026 Payment date: 17th July 2026 Dividend yield will be 3.0%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 15% over the next 3 years. However, it would need to fall by 51% to increase the payout ratio to a potentially unsustainable range.Reported Earnings • May 07First quarter 2026 earnings released: EPS: US$0.27 (vs US$0.022 in 1Q 2025)First quarter 2026 results: EPS: US$0.27 (up from US$0.022 in 1Q 2025). Revenue: US$5.80b (up 19% from 1Q 2025). Net income: US$131.0m (up US$120.0m from 1Q 2025). Profit margin: 2.3% (up from 0.2% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to stay flat during the next 3 years compared to a 7.3% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.Buy Or Sell Opportunity • May 06Now 20% undervaluedOver the last 90 days, the stock has risen 10.0% to US$74.75. The fair value is estimated to be US$93.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.0% per annum. Earnings are forecast to decline by 2.1% per annum over the same time period.お知らせ • Apr 10Nutrien Ltd. to Report Q1, 2026 Results on May 06, 2026Nutrien Ltd. announced that they will report Q1, 2026 results After-Market on May 06, 2026Upcoming Dividend • Mar 24Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 31 March 2026. Payment date: 16 April 2026. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of British dividend payers (5.9%). Lower than average of industry peers (4.4%).Buy Or Sell Opportunity • Mar 20Now 21% undervaluedOver the last 90 days, the stock has risen 20% to US$74.86. The fair value is estimated to be US$94.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.0% per annum. Earnings are forecast to decline by 0.9% per annum over the same time period.New Risk • Mar 18New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.New Risk • Mar 13New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 1.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.Valuation Update With 7 Day Price Move • Mar 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to US$84.85, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 11x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$103 per share.Buy Or Sell Opportunity • Feb 25Now 20% undervaluedOver the last 90 days, the stock has risen 26% to US$71.91. The fair value is estimated to be US$90.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.5% per annum. Earnings are forecast to decline by 1.6% per annum over the same time period.お知らせ • Feb 23Nutrien Ltd., Annual General Meeting, May 06, 2026Nutrien Ltd., Annual General Meeting, May 06, 2026.Declared Dividend • Feb 22Fourth quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 31st March 2026 Payment date: 16th April 2026 Dividend yield will be 3.1%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by both earnings (47% earnings payout ratio) and cash flows (53% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 5.2% over the next 3 years. However, it would need to fall by 48% to increase the payout ratio to a potentially unsustainable range.Reported Earnings • Feb 19Full year 2025 earnings released: EPS: US$4.66 (vs US$1.36 in FY 2024)Full year 2025 results: EPS: US$4.66 (up from US$1.36 in FY 2024). Revenue: US$25.9b (up 3.7% from FY 2024). Net income: US$2.27b (up 236% from FY 2024). Profit margin: 8.7% (up from 2.7% in FY 2024). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 13% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.お知らせ • Feb 19+ 1 more updateNutrien Ltd. Provides Operating Guidance for the Fiscal Year 2026Nutrien Ltd. provided operating guidance for the fiscal year 2026. For the year, the company expects,Potash sales volume guidance of 14.1 million tonnes to 14.8 million tonnes is consistent with our global shipment expectation. Nitrogen sales volume guidance of 9.2 million tonnes to 9.7 million tonnes assumes no production from our Trinidad and New Madrid facility, which accounted for approximately 1.4 million tonnes and 0.2 million tonnes, respectively, in 2025. Nitrogen sales volumes are supported by planned reliability improvements and debottlenecks. Phosphate sales volume guidance of 2.4 million tonnes to 2.6 million tonnes reflect the benefits of reliability improvement initiatives completed in 2025.New Risk • Feb 04New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.4% per year for the foreseeable future. Minor Risk High level of debt (49% net debt to equity).Board Change • Jan 21Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Independent Director Julie Lagacy was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jan 21Nutrien Ltd. to Report Q4, 2025 Results on Feb 18, 2026Nutrien Ltd. announced that they will report Q4, 2025 results After-Market on Feb 18, 2026お知らせ • Dec 12Adecoagro S.A. (NYSE:AGRO) completed the acquisition of 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR).Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million on September 8, 2025. The transaction is subject to customary closing conditions and is expected to be completed before the end of 2025. Rabo Trading Argentina SA acted as financial advisor for Adecoagro S.A. BofA Securities, Inc. acted as financial advisor for Nutrien Ltd. Adecoagro S.A. (NYSE:AGRO) completed the acquisition of 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) on December 10, 2025.お知らせ • Nov 06+ 1 more updateNutrien Ltd. Revises Operating Guidance for the Fiscal Year 2025Nutrien Ltd. revised operating guidance for the fiscal year 2025. For the year, the company expects Potash sales volumes to be in the range of 14 million tonnes to 14.5 million tonnes compared to previous guidance of 13.9 million tonnes to 14.5 million tonnes. Nitrogen sales volumes to be in the range of 10.7 million tonnes to 11 million tonnes compared to previous guidance of 10.7 million tonnes to 11.2 million tonnes. Phosphate sales volumes to be in the range of 2.35 million tonnes to 2.55 million tonnes compared to previous guidance of 2.35 million tonnes to 2.55 million tonnes.お知らせ • Oct 22+ 1 more updateNutrien Ltd. Commences A Controlled Shut Down of Its Trinidad Nitrogen OperationsNutrien Ltd. announced that it has commenced a controlled shut down of its Trinidad Nitrogen operations at the Point Lisas' facility to be effective October 23, 2025. This shutdown is in response to port access restrictions imposed by Trinidad and Tobago's National Energy Corporation (NEC) and a lack of reliable and economic natural gas supply that has reduced the free cash flow contribution of the Trinidad Nitrogen operations over an extended period of time. Nutrien will continue to engage with stakeholders and assess options with respect to its operations in Trinidad. Ammonia and urea sales volumes from Nutrien's Trinidad operations are approximately 85 and 55 thousand tonnes per month, respectively. Nutrien expects to be within its 2025 annual nitrogen sales volume guidance range of 10.7 to 11.2 million tonnes due to the continued strong performance of its North American Nitrogen operations.Buy Or Sell Opportunity • Oct 14Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at US$58.75. The fair value is estimated to be US$73.72, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Earnings per share has declined by 82%. For the next 3 years, revenue is forecast to grow by 2.3% per annum. Earnings are also forecast to grow by 14% per annum over the same time period.お知らせ • Oct 07Nutrien Ltd. to Report Q3, 2025 Results on Nov 05, 2025Nutrien Ltd. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 05, 2025Upcoming Dividend • Sep 22Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 17 October 2025. Payout ratio is on the higher end at 78%, however this is supported by cash flows. Trailing yield: 3.8%. Lower than top quartile of British dividend payers (5.4%). In line with average of industry peers (4.0%).お知らせ • Sep 09Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million.Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million on September 8, 2025. The transaction is subject to customary closing conditions and is expected to be completed before the end of 2025. Rabo Trading Argentina SA acted as financial advisor for Adecoagro S.A. BofA Securities, Inc. acted as financial advisor for Nutrien Ltd.Board Change • Sep 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. Independent Director Julie Lagacy was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Declared Dividend • Aug 17Second quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 29th September 2025 Payment date: 17th October 2025 Dividend yield will be 3.8%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (78% earnings payout ratio) and cash flows (63% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 49% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Buy Or Sell Opportunity • Aug 07Now 22% undervaluedOver the last 90 days, the stock has risen 1.8% to US$56.03. The fair value is estimated to be US$72.00, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Earnings per share has declined by 82%. For the next 3 years, revenue is forecast to grow by 2.2% per annum. Earnings are also forecast to grow by 8.0% per annum over the same time period.お知らせ • Aug 07+ 1 more updateNutrien Declares Quarterly Dividend, Payable on October 17, 2025Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.545 per share payable on October 17, 2025, to shareholders of record on September 29, 2025.お知らせ • Jul 10Nutrien Ltd. to Report Q2, 2025 Results on Aug 06, 2025Nutrien Ltd. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025Upcoming Dividend • Jun 23Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 30 June 2025. Payment date: 18 July 2025. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.6%. Lower than top quartile of British dividend payers (5.6%). Lower than average of industry peers (4.1%).Declared Dividend • May 19First quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 30th June 2025 Payment date: 18th July 2025 Dividend yield will be 3.8%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (202% earnings payout ratio) nor is it covered by cash flows (127% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 125% to bring the payout ratio under control. EPS is expected to grow by 109% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.Buy Or Sell Opportunity • May 14Now 20% undervaluedOver the last 90 days, the stock has risen 11% to US$56.50. The fair value is estimated to be US$70.71, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 73%. For the next 3 years, revenue is forecast to grow by 2.9% per annum. Earnings are also forecast to grow by 28% per annum over the same time period.New Risk • May 09New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 202% Cash payout ratio: 127% Dividend yield: 3.9% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 202% Cash payout ratio: 127% Minor Risks High level of debt (52% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin).お知らせ • May 08+ 1 more updateNutrien Ltd. Provides Operation Guidance for the Year 2025Nutrien Ltd. provided operation guidance for the year 2025. For the year, the company provided Potash sales volume guidance of 13.6 to 14.4 million tonnes is consistent with its historical share of global shipments. Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes reliability improvements and higher operating rates at its North American plants compared to 2024. Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes lower production in the first half of 2025 and improved operating rates in the second half compared to the prior year.Reported Earnings • May 08First quarter 2025 earnings released: EPS: US$0.022 (vs US$0.32 in 1Q 2024)First quarter 2025 results: EPS: US$0.022 (down from US$0.32 in 1Q 2024). Revenue: US$4.87b (down 5.4% from 1Q 2024). Net income: US$11.0m (down 93% from 1Q 2024). Profit margin: 0.2% (down from 3.1% in 1Q 2024). Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 4.5% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.お知らせ • Apr 16Nutrien Ltd. to Report Q1, 2025 Results on May 07, 2025Nutrien Ltd. announced that they will report Q1, 2025 results After-Market on May 07, 2025Buy Or Sell Opportunity • Apr 04Now 23% undervaluedOver the last 90 days, the stock has risen 1.5% to US$47.61. The fair value is estimated to be US$61.60, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 8.6% over the last 3 years. Earnings per share has declined by 55%. For the next 3 years, revenue is forecast to grow by 2.3% per annum. Earnings are also forecast to grow by 23% per annum over the same time period.Declared Dividend • Mar 27Fourth quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 31st March 2025 Payment date: 10th April 2025 Dividend yield will be 4.3%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (158% earnings payout ratio). However, it is covered by cash flows (77% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 76% to bring the payout ratio under control. EPS is expected to grow by 75% over the next 3 years, which should be enough to bring the dividend into a sustainable range.Upcoming Dividend • Mar 24Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 31 March 2025. Payment date: 10 April 2025. The company is paying out more than 100% of its profits and is paying out 77% of its cash flow. Trailing yield: 4.2%. Lower than top quartile of British dividend payers (5.9%). In line with average of industry peers (4.4%).Declared Dividend • Mar 03Fourth quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 31st March 2025 Payment date: 10th April 2025 Dividend yield will be 4.2%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (158% earnings payout ratio). However, it is covered by cash flows (77% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 76% to bring the payout ratio under control. EPS is expected to grow by 75% over the next 3 years, which should be enough to bring the dividend into a sustainable range.お知らせ • Feb 24Nutrien Ltd., Annual General Meeting, May 07, 2025Nutrien Ltd., Annual General Meeting, May 07, 2025.お知らせ • Feb 21Nutrien Ltd. Provides Sales Volume Guidance for the Year 2024Nutrien Ltd. provided sales volume guidance for the year 2024. For the year, the company expects Potash sales volume guidance of 13.6 to 14.4 million tonnes is consistent with the global shipments outlook and accounts for some uncertainty regarding the possible imposition and related impact of US tariffs, as well as global supply availability. Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes continued reliability improvements and higher operating rates at the North American plants. Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes lower production at the White Springs facility in the first half of 2025 and improved operating rates in the second half compared to the prior year.Reported Earnings • Feb 20Full year 2024 earnings released: EPS: US$1.36 (vs US$2.53 in FY 2023)Full year 2024 results: EPS: US$1.36 (down from US$2.53 in FY 2023). Revenue: US$25.0b (down 11% from FY 2023). Net income: US$674.0m (down 46% from FY 2023). Profit margin: 2.7% (down from 4.5% in FY 2023). Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 4.0% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.お知らせ • Feb 20Nutrien Ltd. Declares Quarterly Dividend, Payable on April 10, 2025Nutrien Ltd. announced that its Board of Directors declared a quarterly dividend of USD 0.545 per share payable on April 10, 2025 to shareholders of record on March 31, 2025. This represents an approximately 1% increase from the prior dividend declared on November 6, 2024 and equates to an annualized dividend of USD 2.18 per share.お知らせ • Jan 31Nutrien Ltd. to Report Q4, 2024 Results on Feb 19, 2025Nutrien Ltd. announced that they will report Q4, 2024 results After-Market on Feb 19, 2025Upcoming Dividend • Dec 24Upcoming dividend of US$0.54 per shareEligible shareholders must have bought the stock before 31 December 2024. Payment date: 17 January 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.9%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (3.8%).Declared Dividend • Nov 18Third quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 31st December 2024 Payment date: 17th January 2025 Dividend yield will be 4.7%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (145% earnings payout ratio). However, it is well covered by cash flows (46% cash payout ratio). The dividend has increased by an average of 4.4% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 61% to bring the payout ratio under control. EPS is expected to grow by 80% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.お知らせ • Nov 12Jarden Reportedly Tapped for Incitec Pivot Fertiliser SaleIncitec Pivot Limited (ASX:IPL)'s freshly appointed management has brought in a new investment bank to handle the sale of the distribution arm of its fertiliser business as looks to clear the decks and focus on its future as a mining explosives play. The move to break up the fertiliser unit and sell off the distribution arm was first flagged by DataRoom and announced when the company delivered its annual result on 11 November 2024. It came as the company wiped $941 million off the valuation of the Australian Incitec Pivot fertiliser division. The bank being added to the ticket is Jarden. The move comes as new boss Mauro Neves de Moraes takes over. UBS and Macquarie Capital have previously made efforts to sell the fertiliser business and Macquarie still has a role. This time, though, it appears that the group is motivated to move it off its books and look to a future focused on its more successful commercial explosives operation Dyno Nobel, so it is expected to take a realistic approach to price. Former Incitec Pivot management held out for top dollar when trying to sell its fertiliser unit twice before, and opposed a business break-up. Most buyers were keen to buy the distribution arm and few were interested in taking on the more problematic manufacturing operation. But now, with distribution available separately, the sale process is likely to involve plenty of competitive tension. Australian listed trade buyers like Elders Limited (ASX:ELD) and Ridley Corporation Limited (ASX:RIC) and global strategics like The Mosaic Company (NYSE:MOS), CF Industries Holdings, Inc. (NYSE:CF) and Nutrien Ltd. (TSX:NTR), which has a major Australian presence, will be going head to head with private equity firms like Pacific Equity Partners and BGH Capital, which have been sounded out by investment bankers in recent months. It's clear the market is in favour of the decision, with shares closing higher, despite a thumping $311 million loss and an overall $1 billion writedown to the fertiliser unit. The writedown included $100m for its US operations Most of the rest was linked to the Australian manufacturing operations. The sale process will get going in earnest early next year. The book value is now $414.3 million, compared to more than $1 billion in the past. Private equity in the past has put forward offers of less than $500 million for the fertiliser business, but that was when manufacturing was also part of the picture, although they will be still keen to snap up the operation at an opportunistic price.Reported Earnings • Nov 07Third quarter 2024 earnings released: EPS: US$0.036 (vs US$0.15 in 3Q 2023)Third quarter 2024 results: EPS: US$0.036 (down from US$0.15 in 3Q 2023). Revenue: US$5.09b (down 5.3% from 3Q 2023). Net income: US$18.0m (down 76% from 3Q 2023). Profit margin: 0.4% (down from 1.4% in 3Q 2023). Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 6.5% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.お知らせ • Nov 07+ 1 more updateNutrien Ltd. Revises Operational Guidance for the Year 2024Nutrien Ltd. revised operational guidance for the year 2024. For the year, potash sales volume guidance was raised to 13.5 million tonnes to 13.9 million tonnes against previous guidance range of 13.2 million tonnes to 13.8 million tonnes due to the continued strength of global demand. The range reflects the company’s scheduled maintenance downtime in the fourth quarter and the assumption of a relatively short duration labor disruption at the Port of Vancouver. Nitrogen sales volume guidance was lowered to 10.6 million tonnes to 10.8 million tonnes against previous guidance range of 10.7 million tonnes to 11.1 million tonnes due to extended turnarounds and unplanned outages in the third quarter, including the impact of weather-related events. Phosphate sales volume guidance was lowered to 2.4 million tonnes to 2.5 million tonnes against previous guidance range of 2.5 million tonnes to 2.6 million tonnes due to weather-related production impacts in the second half of 2024.お知らせ • Oct 11Nutrien Ltd. to Report Q3, 2024 Results on Nov 06, 2024Nutrien Ltd. announced that they will report Q3, 2024 results After-Market on Nov 06, 2024Upcoming Dividend • Sep 20Upcoming dividend of US$0.54 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 18 October 2024. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.5%. Lower than top quartile of British dividend payers (5.5%). Higher than average of industry peers (3.3%).Recent Insider Transactions • Aug 25Executive VP & Chief Commercial Officer recently bought US$164k worth of stockOn the 20th of August, Mark Thompson bought around 4k shares on-market at roughly US$46.93 per share. This transaction amounted to 29% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$654k more in shares than they have sold in the last 12 months.Declared Dividend • Aug 11Second quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 27th September 2024 Payment date: 18th October 2024 Dividend yield will be 4.7%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (134% earnings payout ratio). However, it is well covered by cash flows (40% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 49% to bring the payout ratio under control. EPS is expected to grow by 56% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.お知らせ • Aug 08Nutrien Ltd. Announces Chief Financial Officer ChangesNutrien Ltd. announces the appointment of Mark Thompson as Chief Financial Officer, effective August 26, 2024. In alignment with Nutrien's succession plan, Mr. Thompson succeeds Pedro Farah, who will remain with Nutrien in an advisory capacity until his departure on December 31, 2024. Mr. Thompson has been with the Company since 2011, currently serving as Executive Vice President and Chief Commercial Officer. Prior to his current position he held numerous executive and senior leadership roles across the company, including Chief Strategy & Sustainability Officer, Chief Corporate Development & Strategy Officer, and Vice President of Business Development for Nutrien’s Retail business. He earned his Bachelor of Commerce (Finance) and Bachelor of Arts degrees from the University of Saskatchewan and holds the Chartered Financial Analyst (CFA) designation.Reported Earnings • Aug 08Second quarter 2024 earnings released: EPS: US$0.78 (vs US$0.89 in 2Q 2023)Second quarter 2024 results: EPS: US$0.78 (down from US$0.89 in 2Q 2023). Revenue: US$9.92b (down 13% from 2Q 2023). Net income: US$385.0m (down 13% from 2Q 2023). Profit margin: 3.9% (in line with 2Q 2023). Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 5.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 10% per year.お知らせ • Aug 08Nutrien Ltd. Announces the Appointment of Mark Thompson as Executive Vice President, Effective August 26, 2024Nutrien Ltd. announced the appointment of Mark Thompson as Executive Vice President, effective August 26, 2024. Mr. Thompson has been with the Company since 2011, currently serving as Executive Vice President and Chief Commercial Officer. Prior to his current position he held numerous executive and senior leadership roles across the company, including Chief Strategy & Sustainability Officer, Chief Corporate Development & Strategy Officer, and Vice President of Business Development for Nutrien’s Retail business. He earned his Bachelor of Commerce (Finance) and Bachelor of Arts degrees from the University of Saskatchewan and holds the Chartered Financial Analyst (CFA) designation.お知らせ • Jun 18Nutrien Ltd. to Report Q2, 2024 Results on Aug 07, 2024Nutrien Ltd. announced that they will report Q2, 2024 results on Aug 07, 2024Buy Or Sell Opportunity • Jun 11Now 22% undervaluedThe stock has been flat over the last 90 days, currently trading at US$53.24. The fair value is estimated to be US$68.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.5% over the last 3 years. Earnings per share has grown by 8.6%. For the next 3 years, revenue is forecast to grow by 1.9% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.Declared Dividend • May 12First quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 28th June 2024 Payment date: 19th July 2024 Dividend yield will be 3.7%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (125% earnings payout ratio). However, it is well covered by cash flows (37% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 39% to bring the payout ratio under control. EPS is expected to grow by 38% over the next 3 years, which should be enough to bring the dividend into a sustainable range.お知らせ • May 10Nutrien Ltd. Approves the Election of Julie A. Lagacy as DirectorNutrien Ltd. at its annual meeting of shareholders held on May 8, 2024 approved the election of Julie A. Lagacy as Director.Reported Earnings • May 09First quarter 2024 earnings released: EPS: US$0.32 (vs US$1.14 in 1Q 2023)First quarter 2024 results: EPS: US$0.32 (down from US$1.14 in 1Q 2023). Revenue: US$5.15b (down 13% from 1Q 2023). Net income: US$158.0m (down 72% from 1Q 2023). Profit margin: 3.1% (down from 9.7% in 1Q 2023). Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.お知らせ • May 09Nutrien Ltd. Declares Quarterly Dividend, Payable on July 19, 2024Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.54 per share payable on July 19, 2024, to shareholders of record on June 28, 2024.お知らせ • Apr 15Nutrien Reportedly Seeks an Exit from its Retail Assets in Argentina, Chile and UruguayCanadian fertiliser giant Nutrien Ltd. (TSX:NTR) is seeking an exit from its retail assets in Argentina, Chile and Uruguay, Reuters reported citing a statement from the company. The move is said to be aimed at simplifying the company’s business and concentrating on key markets, such as Brazil.お知らせ • Apr 11Nutrien Ltd. to Report Q1, 2024 Results on May 08, 2024Nutrien Ltd. announced that they will report Q1, 2024 results After-Market on May 08, 2024Upcoming Dividend • Mar 20Upcoming dividend of US$0.54 per shareEligible shareholders must have bought the stock before 27 March 2024. Payment date: 11 April 2024. Payout ratio is on the higher end at 84%, however this is supported by cash flows. Trailing yield: 4.1%. Lower than top quartile of British dividend payers (6.2%). Higher than average of industry peers (3.0%).Declared Dividend • Mar 04Fourth quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 27th March 2024 Payment date: 11th April 2024 Dividend yield will be 4.0%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (84% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 25% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Feb 24Nutrien Ltd., Annual General Meeting, May 08, 2024Nutrien Ltd., Annual General Meeting, May 08, 2024.お知らせ • Feb 22Nutrien Ltd. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023Nutrien Ltd. reported impairment charges for the fourth quarter ended December 31, 2023. For the quarter, the company recognized a $76 million non-cash impairment in Nitrogen segment relating to Trinidad property, plant and equipment due to a new natural gas contract and the resulting outlook for higher expected natural gas costs and constrained near-term availability.New Risk • Feb 22New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (41% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.5% net profit margin).Reported Earnings • Feb 22Full year 2023 earnings released: EPS: US$2.53 (vs US$14.23 in FY 2022)Full year 2023 results: EPS: US$2.53 (down from US$14.23 in FY 2022). Revenue: US$28.1b (down 24% from FY 2022). Net income: US$1.26b (down 84% from FY 2022). Profit margin: 4.5% (down from 21% in FY 2022). Revenue is forecast to stay flat during the next 3 years compared to a 4.1% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.お知らせ • Feb 22+ 1 more updateNutrien Ltd. Revises Sales Volume Guidance for the Year 2024Nutrien Ltd. revised sales volume guidance for the year 2024. For the year, the company expects Potash sales volume guidance of 13.0 to 13.8 million tonnes assumes demand growth in offshore markets and a return to more normal Canpotex port operations in 2024. In North America, The company expects increased first quarter sales volumes compared to the prior year due to strong customer engagement to refill depleted inventories. Nitrogen sales volume guidance of 10.6 to 11.2 million tonnes assumes higher operating rates at US and Trinidad plants compared to 2023. Phosphate sales volume guidance of 2.6 to 2.8 million tonnes assumes improved operating rates compared to the prior year.お知らせ • Jan 24Nutrien Ltd. to Report Q4, 2023 Results on Feb 21, 2024Nutrien Ltd. announced that they will report Q4, 2023 results After-Market on Feb 21, 2024Upcoming Dividend • Dec 21Upcoming dividend of US$0.53 per share at 3.8% yieldEligible shareholders must have bought the stock before 28 December 2023. Payment date: 12 January 2024. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 3.8%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.9%).Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: US$0.15 (vs US$2.95 in 3Q 2022)Third quarter 2023 results: EPS: US$0.15 (down from US$2.95 in 3Q 2022). Revenue: US$5.37b (down 33% from 3Q 2022). Net income: US$75.0m (down 95% from 3Q 2022). Profit margin: 1.4% (down from 20% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.お知らせ • Nov 02Nutrien Ltd. Declares Quarterly Dividend, Payable on January 12, 2024Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.53 per share payable on January 12, 2024, to shareholders of record on December 29, 2023.お知らせ • Oct 06Nutrien Ltd. to Report Q3, 2023 Results on Nov 01, 2023Nutrien Ltd. announced that they will report Q3, 2023 results After-Market on Nov 01, 2023Upcoming Dividend • Sep 21Upcoming dividend of US$0.53 per share at 3.4% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 13 October 2023. Payout ratio is a comfortable 28% and this is well supported by cash flows. Trailing yield: 3.4%. Lower than top quartile of British dividend payers (6.2%). Higher than average of industry peers (3.0%).New Risk • Aug 04New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 11% Last year net profit margin: 20% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 14% per year for the foreseeable future. Minor Risks High level of debt (46% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (11% net profit margin).Reported Earnings • Aug 03Second quarter 2023 earnings released: EPS: US$0.89 (vs US$6.53 in 2Q 2022)Second quarter 2023 results: EPS: US$0.89 (down from US$6.53 in 2Q 2022). Revenue: US$11.4b (down 20% from 2Q 2022). Net income: US$440.0m (down 88% from 2Q 2022). Profit margin: 3.9% (down from 25% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Revenue is expected to fall by 2.5% p.a. on average during the next 3 years compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Aug 03Nutrien Ltd. Declares Quarterly Dividend, Payable on October 13, 2023Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.53 per share payable on October 13, 2023, to shareholders of record on September 29, 2023.お知らせ • Jun 29Nutrien Ltd. to Report Q2, 2023 Results on Aug 02, 2023Nutrien Ltd. announced that they will report Q2, 2023 results After-Market on Aug 02, 2023Upcoming Dividend • Jun 22Upcoming dividend of US$0.53 per share at 3.5% yieldEligible shareholders must have bought the stock before 29 June 2023. Payment date: 14 July 2023. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 3.5%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.8%).株主還元0NHSGB ChemicalsGB 市場7D-7.0%5.0%0.9%1Y17.2%23.2%19.6%株主還元を見る業界別リターン: 0NHS過去 1 年間で23.2 % の収益を上げたUK Chemicals業界を下回りました。リターン対市場: 0NHSは、過去 1 年間で19.6 % のリターンを上げたUK市場を下回りました。価格変動Is 0NHS's price volatile compared to industry and market?0NHS volatility0NHS Average Weekly Movement4.0%Chemicals Industry Average Movement6.3%Market Average Movement5.1%10% most volatile stocks in GB Market10.4%10% least volatile stocks in GB Market2.7%安定した株価: 0NHS 、 UK市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 0NHSの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト201725,500Ken Seitzwww.nutrien.comNutrien Ltd.は農作物の投入資材とサービスを提供している。同社は4つのセグメントで事業を展開している：小売、カリ、窒素、リン酸。小売部門は、農作物用栄養剤、農作物保護製品、種子、商品の販売、農学的応用および融資サービスやソリューションの提供、独自の農作物用栄養剤、農作物保護製品、種子製品などの独自製品の生産を行っている。カリ部門にはカリの採掘と加工が含まれる。窒素部門はアンモニア生産施設を所有・運営し、アンモニア、尿素、硝酸アンモニウム（UAN）、尿素溶液、硝酸、硝酸アンモニウムのほか、環境に配慮した窒素や硫安を提供している。リン酸事業では、固形・液体リン酸肥料、リン酸飼料、飼料や工業製品に使用される精製リン酸を製造・販売している。同社は2017年に法人化され、カナダのサスカトゥーンに本社を置いている。もっと見るNutrien Ltd. 基礎のまとめNutrien の収益と売上を時価総額と比較するとどうか。0NHS 基礎統計学時価総額US$30.77b収益（TTM）US$2.38b売上高(TTM)US$27.29b12.9xPER（株価収益率1.1xP/Sレシオ0NHS は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計0NHS 損益計算書（TTM）収益US$27.29b売上原価US$18.54b売上総利益US$8.75bその他の費用US$6.37b収益US$2.38b直近の収益報告Jun 30, 2026次回決算日Nov 05, 2026一株当たり利益（EPS）4.99グロス・マージン32.06%純利益率8.72%有利子負債／自己資本比率43.9%0NHS の長期的なパフォーマンスは？過去の実績と比較を見る配当金3.4%現在の配当利回り44%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/09 23:36終値2026/08/07 00:00収益2026/06/30年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nutrien Ltd. 15 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。51 アナリスト機関Harriet LiAccountability Research CorporationKeith CarpenterATB CormarkBenjamin TheurerBarclays48 その他のアナリストを表示
Reported Earnings • Aug 07Second quarter 2026 earnings released: EPS: US$2.53 (vs US$2.51 in 2Q 2025)Second quarter 2026 results: EPS: US$2.53. Revenue: US$10.6b (up 4.0% from 2Q 2025). Net income: US$1.21b (flat on 2Q 2025). Profit margin: 11% (in line with 2Q 2025). Revenue is forecast to stay flat during the next 3 years compared to a 11% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Aug 06Nutrien Ltd. Provides Operating Guidance for the Fiscal Year 2026Nutrien Ltd. provided operating guidance for the fiscal year 2026. For the year, the company expects Potash sales volume guidance was increased to 14.2 million to 14.8 million tonnes due to strong demand in key offshore markets and is consistent with global shipment expectation. Nitrogen sales volume guidance of 9.2 million to 9.7 million tonnes is supported by planned reliability improvements and debottlenecking initiatives. The range reflects the completion of planned turnarounds in the third quarter of 2026 and higher ammonia operating rates in the fourth quarter compared to the prior year. Phosphate sales volume guidance of 2.4 million to 2.6 million tonnes reflects the benefits of reliability improvement initiatives completed in 2025.
お知らせ • Jul 23Nutrien Ltd. to Report Q4, 2026 Results on Feb 18, 2027Nutrien Ltd. announced that they will report Q4, 2026 results on Feb 18, 2027
Buy Or Sell Opportunity • Jul 15Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.5% to US$67.19. The fair value is estimated to be US$84.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has declined by 37%. For the next 3 years, revenue is forecast to grow by 0.2% per annum. Earnings are forecast to decline by 6.7% per annum over the same time period.
Upcoming Dividend • Jun 23Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 30 June 2026. Payment date: 17 July 2026. Payout ratio is a comfortable 44% and this is well supported by cash flows. Trailing yield: 3.5%. Lower than top quartile of British dividend payers (5.6%). In line with average of industry peers (3.7%).
Buy Or Sell Opportunity • Jun 05Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 13% to US$67.38. The fair value is estimated to be US$85.61, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has declined by 37%. For the next 3 years, revenue is forecast to grow by 0.3% per annum. Earnings are forecast to decline by 6.9% per annum over the same time period.
Reported Earnings • Aug 07Second quarter 2026 earnings released: EPS: US$2.53 (vs US$2.51 in 2Q 2025)Second quarter 2026 results: EPS: US$2.53. Revenue: US$10.6b (up 4.0% from 2Q 2025). Net income: US$1.21b (flat on 2Q 2025). Profit margin: 11% (in line with 2Q 2025). Revenue is forecast to stay flat during the next 3 years compared to a 11% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Aug 06Nutrien Ltd. Provides Operating Guidance for the Fiscal Year 2026Nutrien Ltd. provided operating guidance for the fiscal year 2026. For the year, the company expects Potash sales volume guidance was increased to 14.2 million to 14.8 million tonnes due to strong demand in key offshore markets and is consistent with global shipment expectation. Nitrogen sales volume guidance of 9.2 million to 9.7 million tonnes is supported by planned reliability improvements and debottlenecking initiatives. The range reflects the completion of planned turnarounds in the third quarter of 2026 and higher ammonia operating rates in the fourth quarter compared to the prior year. Phosphate sales volume guidance of 2.4 million to 2.6 million tonnes reflects the benefits of reliability improvement initiatives completed in 2025.
お知らせ • Jul 23Nutrien Ltd. to Report Q4, 2026 Results on Feb 18, 2027Nutrien Ltd. announced that they will report Q4, 2026 results on Feb 18, 2027
Buy Or Sell Opportunity • Jul 15Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.5% to US$67.19. The fair value is estimated to be US$84.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has declined by 37%. For the next 3 years, revenue is forecast to grow by 0.2% per annum. Earnings are forecast to decline by 6.7% per annum over the same time period.
Upcoming Dividend • Jun 23Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 30 June 2026. Payment date: 17 July 2026. Payout ratio is a comfortable 44% and this is well supported by cash flows. Trailing yield: 3.5%. Lower than top quartile of British dividend payers (5.6%). In line with average of industry peers (3.7%).
Buy Or Sell Opportunity • Jun 05Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 13% to US$67.38. The fair value is estimated to be US$85.61, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has declined by 37%. For the next 3 years, revenue is forecast to grow by 0.3% per annum. Earnings are forecast to decline by 6.9% per annum over the same time period.
Declared Dividend • May 13First quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 30th June 2026 Payment date: 17th July 2026 Dividend yield will be 3.0%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 15% over the next 3 years. However, it would need to fall by 51% to increase the payout ratio to a potentially unsustainable range.
Reported Earnings • May 07First quarter 2026 earnings released: EPS: US$0.27 (vs US$0.022 in 1Q 2025)First quarter 2026 results: EPS: US$0.27 (up from US$0.022 in 1Q 2025). Revenue: US$5.80b (up 19% from 1Q 2025). Net income: US$131.0m (up US$120.0m from 1Q 2025). Profit margin: 2.3% (up from 0.2% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to stay flat during the next 3 years compared to a 7.3% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
Buy Or Sell Opportunity • May 06Now 20% undervaluedOver the last 90 days, the stock has risen 10.0% to US$74.75. The fair value is estimated to be US$93.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.0% per annum. Earnings are forecast to decline by 2.1% per annum over the same time period.
お知らせ • Apr 10Nutrien Ltd. to Report Q1, 2026 Results on May 06, 2026Nutrien Ltd. announced that they will report Q1, 2026 results After-Market on May 06, 2026
Upcoming Dividend • Mar 24Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 31 March 2026. Payment date: 16 April 2026. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of British dividend payers (5.9%). Lower than average of industry peers (4.4%).
Buy Or Sell Opportunity • Mar 20Now 21% undervaluedOver the last 90 days, the stock has risen 20% to US$74.86. The fair value is estimated to be US$94.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.0% per annum. Earnings are forecast to decline by 0.9% per annum over the same time period.
New Risk • Mar 18New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.
New Risk • Mar 13New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 1.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.
Valuation Update With 7 Day Price Move • Mar 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to US$84.85, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 11x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$103 per share.
Buy Or Sell Opportunity • Feb 25Now 20% undervaluedOver the last 90 days, the stock has risen 26% to US$71.91. The fair value is estimated to be US$90.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.5% per annum. Earnings are forecast to decline by 1.6% per annum over the same time period.
お知らせ • Feb 23Nutrien Ltd., Annual General Meeting, May 06, 2026Nutrien Ltd., Annual General Meeting, May 06, 2026.
Declared Dividend • Feb 22Fourth quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 31st March 2026 Payment date: 16th April 2026 Dividend yield will be 3.1%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by both earnings (47% earnings payout ratio) and cash flows (53% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 5.2% over the next 3 years. However, it would need to fall by 48% to increase the payout ratio to a potentially unsustainable range.
Reported Earnings • Feb 19Full year 2025 earnings released: EPS: US$4.66 (vs US$1.36 in FY 2024)Full year 2025 results: EPS: US$4.66 (up from US$1.36 in FY 2024). Revenue: US$25.9b (up 3.7% from FY 2024). Net income: US$2.27b (up 236% from FY 2024). Profit margin: 8.7% (up from 2.7% in FY 2024). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 13% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 19+ 1 more updateNutrien Ltd. Provides Operating Guidance for the Fiscal Year 2026Nutrien Ltd. provided operating guidance for the fiscal year 2026. For the year, the company expects,Potash sales volume guidance of 14.1 million tonnes to 14.8 million tonnes is consistent with our global shipment expectation. Nitrogen sales volume guidance of 9.2 million tonnes to 9.7 million tonnes assumes no production from our Trinidad and New Madrid facility, which accounted for approximately 1.4 million tonnes and 0.2 million tonnes, respectively, in 2025. Nitrogen sales volumes are supported by planned reliability improvements and debottlenecks. Phosphate sales volume guidance of 2.4 million tonnes to 2.6 million tonnes reflect the benefits of reliability improvement initiatives completed in 2025.
New Risk • Feb 04New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.4% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.4% per year for the foreseeable future. Minor Risk High level of debt (49% net debt to equity).
Board Change • Jan 21Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Independent Director Julie Lagacy was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jan 21Nutrien Ltd. to Report Q4, 2025 Results on Feb 18, 2026Nutrien Ltd. announced that they will report Q4, 2025 results After-Market on Feb 18, 2026
お知らせ • Dec 12Adecoagro S.A. (NYSE:AGRO) completed the acquisition of 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR).Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million on September 8, 2025. The transaction is subject to customary closing conditions and is expected to be completed before the end of 2025. Rabo Trading Argentina SA acted as financial advisor for Adecoagro S.A. BofA Securities, Inc. acted as financial advisor for Nutrien Ltd. Adecoagro S.A. (NYSE:AGRO) completed the acquisition of 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) on December 10, 2025.
お知らせ • Nov 06+ 1 more updateNutrien Ltd. Revises Operating Guidance for the Fiscal Year 2025Nutrien Ltd. revised operating guidance for the fiscal year 2025. For the year, the company expects Potash sales volumes to be in the range of 14 million tonnes to 14.5 million tonnes compared to previous guidance of 13.9 million tonnes to 14.5 million tonnes. Nitrogen sales volumes to be in the range of 10.7 million tonnes to 11 million tonnes compared to previous guidance of 10.7 million tonnes to 11.2 million tonnes. Phosphate sales volumes to be in the range of 2.35 million tonnes to 2.55 million tonnes compared to previous guidance of 2.35 million tonnes to 2.55 million tonnes.
お知らせ • Oct 22+ 1 more updateNutrien Ltd. Commences A Controlled Shut Down of Its Trinidad Nitrogen OperationsNutrien Ltd. announced that it has commenced a controlled shut down of its Trinidad Nitrogen operations at the Point Lisas' facility to be effective October 23, 2025. This shutdown is in response to port access restrictions imposed by Trinidad and Tobago's National Energy Corporation (NEC) and a lack of reliable and economic natural gas supply that has reduced the free cash flow contribution of the Trinidad Nitrogen operations over an extended period of time. Nutrien will continue to engage with stakeholders and assess options with respect to its operations in Trinidad. Ammonia and urea sales volumes from Nutrien's Trinidad operations are approximately 85 and 55 thousand tonnes per month, respectively. Nutrien expects to be within its 2025 annual nitrogen sales volume guidance range of 10.7 to 11.2 million tonnes due to the continued strong performance of its North American Nitrogen operations.
Buy Or Sell Opportunity • Oct 14Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at US$58.75. The fair value is estimated to be US$73.72, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Earnings per share has declined by 82%. For the next 3 years, revenue is forecast to grow by 2.3% per annum. Earnings are also forecast to grow by 14% per annum over the same time period.
お知らせ • Oct 07Nutrien Ltd. to Report Q3, 2025 Results on Nov 05, 2025Nutrien Ltd. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 05, 2025
Upcoming Dividend • Sep 22Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 17 October 2025. Payout ratio is on the higher end at 78%, however this is supported by cash flows. Trailing yield: 3.8%. Lower than top quartile of British dividend payers (5.4%). In line with average of industry peers (4.0%).
お知らせ • Sep 09Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million.Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million on September 8, 2025. The transaction is subject to customary closing conditions and is expected to be completed before the end of 2025. Rabo Trading Argentina SA acted as financial advisor for Adecoagro S.A. BofA Securities, Inc. acted as financial advisor for Nutrien Ltd.
Board Change • Sep 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. Independent Director Julie Lagacy was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Declared Dividend • Aug 17Second quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 29th September 2025 Payment date: 17th October 2025 Dividend yield will be 3.8%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (78% earnings payout ratio) and cash flows (63% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 49% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Buy Or Sell Opportunity • Aug 07Now 22% undervaluedOver the last 90 days, the stock has risen 1.8% to US$56.03. The fair value is estimated to be US$72.00, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Earnings per share has declined by 82%. For the next 3 years, revenue is forecast to grow by 2.2% per annum. Earnings are also forecast to grow by 8.0% per annum over the same time period.
お知らせ • Aug 07+ 1 more updateNutrien Declares Quarterly Dividend, Payable on October 17, 2025Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.545 per share payable on October 17, 2025, to shareholders of record on September 29, 2025.
お知らせ • Jul 10Nutrien Ltd. to Report Q2, 2025 Results on Aug 06, 2025Nutrien Ltd. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025
Upcoming Dividend • Jun 23Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 30 June 2025. Payment date: 18 July 2025. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.6%. Lower than top quartile of British dividend payers (5.6%). Lower than average of industry peers (4.1%).
Declared Dividend • May 19First quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 30th June 2025 Payment date: 18th July 2025 Dividend yield will be 3.8%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (202% earnings payout ratio) nor is it covered by cash flows (127% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 125% to bring the payout ratio under control. EPS is expected to grow by 109% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.
Buy Or Sell Opportunity • May 14Now 20% undervaluedOver the last 90 days, the stock has risen 11% to US$56.50. The fair value is estimated to be US$70.71, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 73%. For the next 3 years, revenue is forecast to grow by 2.9% per annum. Earnings are also forecast to grow by 28% per annum over the same time period.
New Risk • May 09New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 202% Cash payout ratio: 127% Dividend yield: 3.9% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 202% Cash payout ratio: 127% Minor Risks High level of debt (52% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin).
お知らせ • May 08+ 1 more updateNutrien Ltd. Provides Operation Guidance for the Year 2025Nutrien Ltd. provided operation guidance for the year 2025. For the year, the company provided Potash sales volume guidance of 13.6 to 14.4 million tonnes is consistent with its historical share of global shipments. Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes reliability improvements and higher operating rates at its North American plants compared to 2024. Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes lower production in the first half of 2025 and improved operating rates in the second half compared to the prior year.
Reported Earnings • May 08First quarter 2025 earnings released: EPS: US$0.022 (vs US$0.32 in 1Q 2024)First quarter 2025 results: EPS: US$0.022 (down from US$0.32 in 1Q 2024). Revenue: US$4.87b (down 5.4% from 1Q 2024). Net income: US$11.0m (down 93% from 1Q 2024). Profit margin: 0.2% (down from 3.1% in 1Q 2024). Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 4.5% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 16Nutrien Ltd. to Report Q1, 2025 Results on May 07, 2025Nutrien Ltd. announced that they will report Q1, 2025 results After-Market on May 07, 2025
Buy Or Sell Opportunity • Apr 04Now 23% undervaluedOver the last 90 days, the stock has risen 1.5% to US$47.61. The fair value is estimated to be US$61.60, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 8.6% over the last 3 years. Earnings per share has declined by 55%. For the next 3 years, revenue is forecast to grow by 2.3% per annum. Earnings are also forecast to grow by 23% per annum over the same time period.
Declared Dividend • Mar 27Fourth quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 31st March 2025 Payment date: 10th April 2025 Dividend yield will be 4.3%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (158% earnings payout ratio). However, it is covered by cash flows (77% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 76% to bring the payout ratio under control. EPS is expected to grow by 75% over the next 3 years, which should be enough to bring the dividend into a sustainable range.
Upcoming Dividend • Mar 24Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 31 March 2025. Payment date: 10 April 2025. The company is paying out more than 100% of its profits and is paying out 77% of its cash flow. Trailing yield: 4.2%. Lower than top quartile of British dividend payers (5.9%). In line with average of industry peers (4.4%).
Declared Dividend • Mar 03Fourth quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 31st March 2025 Payment date: 10th April 2025 Dividend yield will be 4.2%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (158% earnings payout ratio). However, it is covered by cash flows (77% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 76% to bring the payout ratio under control. EPS is expected to grow by 75% over the next 3 years, which should be enough to bring the dividend into a sustainable range.
お知らせ • Feb 24Nutrien Ltd., Annual General Meeting, May 07, 2025Nutrien Ltd., Annual General Meeting, May 07, 2025.
お知らせ • Feb 21Nutrien Ltd. Provides Sales Volume Guidance for the Year 2024Nutrien Ltd. provided sales volume guidance for the year 2024. For the year, the company expects Potash sales volume guidance of 13.6 to 14.4 million tonnes is consistent with the global shipments outlook and accounts for some uncertainty regarding the possible imposition and related impact of US tariffs, as well as global supply availability. Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes continued reliability improvements and higher operating rates at the North American plants. Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes lower production at the White Springs facility in the first half of 2025 and improved operating rates in the second half compared to the prior year.
Reported Earnings • Feb 20Full year 2024 earnings released: EPS: US$1.36 (vs US$2.53 in FY 2023)Full year 2024 results: EPS: US$1.36 (down from US$2.53 in FY 2023). Revenue: US$25.0b (down 11% from FY 2023). Net income: US$674.0m (down 46% from FY 2023). Profit margin: 2.7% (down from 4.5% in FY 2023). Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 4.0% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 20Nutrien Ltd. Declares Quarterly Dividend, Payable on April 10, 2025Nutrien Ltd. announced that its Board of Directors declared a quarterly dividend of USD 0.545 per share payable on April 10, 2025 to shareholders of record on March 31, 2025. This represents an approximately 1% increase from the prior dividend declared on November 6, 2024 and equates to an annualized dividend of USD 2.18 per share.
お知らせ • Jan 31Nutrien Ltd. to Report Q4, 2024 Results on Feb 19, 2025Nutrien Ltd. announced that they will report Q4, 2024 results After-Market on Feb 19, 2025
Upcoming Dividend • Dec 24Upcoming dividend of US$0.54 per shareEligible shareholders must have bought the stock before 31 December 2024. Payment date: 17 January 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.9%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (3.8%).
Declared Dividend • Nov 18Third quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 31st December 2024 Payment date: 17th January 2025 Dividend yield will be 4.7%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (145% earnings payout ratio). However, it is well covered by cash flows (46% cash payout ratio). The dividend has increased by an average of 4.4% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 61% to bring the payout ratio under control. EPS is expected to grow by 80% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
お知らせ • Nov 12Jarden Reportedly Tapped for Incitec Pivot Fertiliser SaleIncitec Pivot Limited (ASX:IPL)'s freshly appointed management has brought in a new investment bank to handle the sale of the distribution arm of its fertiliser business as looks to clear the decks and focus on its future as a mining explosives play. The move to break up the fertiliser unit and sell off the distribution arm was first flagged by DataRoom and announced when the company delivered its annual result on 11 November 2024. It came as the company wiped $941 million off the valuation of the Australian Incitec Pivot fertiliser division. The bank being added to the ticket is Jarden. The move comes as new boss Mauro Neves de Moraes takes over. UBS and Macquarie Capital have previously made efforts to sell the fertiliser business and Macquarie still has a role. This time, though, it appears that the group is motivated to move it off its books and look to a future focused on its more successful commercial explosives operation Dyno Nobel, so it is expected to take a realistic approach to price. Former Incitec Pivot management held out for top dollar when trying to sell its fertiliser unit twice before, and opposed a business break-up. Most buyers were keen to buy the distribution arm and few were interested in taking on the more problematic manufacturing operation. But now, with distribution available separately, the sale process is likely to involve plenty of competitive tension. Australian listed trade buyers like Elders Limited (ASX:ELD) and Ridley Corporation Limited (ASX:RIC) and global strategics like The Mosaic Company (NYSE:MOS), CF Industries Holdings, Inc. (NYSE:CF) and Nutrien Ltd. (TSX:NTR), which has a major Australian presence, will be going head to head with private equity firms like Pacific Equity Partners and BGH Capital, which have been sounded out by investment bankers in recent months. It's clear the market is in favour of the decision, with shares closing higher, despite a thumping $311 million loss and an overall $1 billion writedown to the fertiliser unit. The writedown included $100m for its US operations Most of the rest was linked to the Australian manufacturing operations. The sale process will get going in earnest early next year. The book value is now $414.3 million, compared to more than $1 billion in the past. Private equity in the past has put forward offers of less than $500 million for the fertiliser business, but that was when manufacturing was also part of the picture, although they will be still keen to snap up the operation at an opportunistic price.
Reported Earnings • Nov 07Third quarter 2024 earnings released: EPS: US$0.036 (vs US$0.15 in 3Q 2023)Third quarter 2024 results: EPS: US$0.036 (down from US$0.15 in 3Q 2023). Revenue: US$5.09b (down 5.3% from 3Q 2023). Net income: US$18.0m (down 76% from 3Q 2023). Profit margin: 0.4% (down from 1.4% in 3Q 2023). Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 6.5% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
お知らせ • Nov 07+ 1 more updateNutrien Ltd. Revises Operational Guidance for the Year 2024Nutrien Ltd. revised operational guidance for the year 2024. For the year, potash sales volume guidance was raised to 13.5 million tonnes to 13.9 million tonnes against previous guidance range of 13.2 million tonnes to 13.8 million tonnes due to the continued strength of global demand. The range reflects the company’s scheduled maintenance downtime in the fourth quarter and the assumption of a relatively short duration labor disruption at the Port of Vancouver. Nitrogen sales volume guidance was lowered to 10.6 million tonnes to 10.8 million tonnes against previous guidance range of 10.7 million tonnes to 11.1 million tonnes due to extended turnarounds and unplanned outages in the third quarter, including the impact of weather-related events. Phosphate sales volume guidance was lowered to 2.4 million tonnes to 2.5 million tonnes against previous guidance range of 2.5 million tonnes to 2.6 million tonnes due to weather-related production impacts in the second half of 2024.
お知らせ • Oct 11Nutrien Ltd. to Report Q3, 2024 Results on Nov 06, 2024Nutrien Ltd. announced that they will report Q3, 2024 results After-Market on Nov 06, 2024
Upcoming Dividend • Sep 20Upcoming dividend of US$0.54 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 18 October 2024. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.5%. Lower than top quartile of British dividend payers (5.5%). Higher than average of industry peers (3.3%).
Recent Insider Transactions • Aug 25Executive VP & Chief Commercial Officer recently bought US$164k worth of stockOn the 20th of August, Mark Thompson bought around 4k shares on-market at roughly US$46.93 per share. This transaction amounted to 29% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$654k more in shares than they have sold in the last 12 months.
Declared Dividend • Aug 11Second quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 27th September 2024 Payment date: 18th October 2024 Dividend yield will be 4.7%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (134% earnings payout ratio). However, it is well covered by cash flows (40% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 49% to bring the payout ratio under control. EPS is expected to grow by 56% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
お知らせ • Aug 08Nutrien Ltd. Announces Chief Financial Officer ChangesNutrien Ltd. announces the appointment of Mark Thompson as Chief Financial Officer, effective August 26, 2024. In alignment with Nutrien's succession plan, Mr. Thompson succeeds Pedro Farah, who will remain with Nutrien in an advisory capacity until his departure on December 31, 2024. Mr. Thompson has been with the Company since 2011, currently serving as Executive Vice President and Chief Commercial Officer. Prior to his current position he held numerous executive and senior leadership roles across the company, including Chief Strategy & Sustainability Officer, Chief Corporate Development & Strategy Officer, and Vice President of Business Development for Nutrien’s Retail business. He earned his Bachelor of Commerce (Finance) and Bachelor of Arts degrees from the University of Saskatchewan and holds the Chartered Financial Analyst (CFA) designation.
Reported Earnings • Aug 08Second quarter 2024 earnings released: EPS: US$0.78 (vs US$0.89 in 2Q 2023)Second quarter 2024 results: EPS: US$0.78 (down from US$0.89 in 2Q 2023). Revenue: US$9.92b (down 13% from 2Q 2023). Net income: US$385.0m (down 13% from 2Q 2023). Profit margin: 3.9% (in line with 2Q 2023). Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 5.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 10% per year.
お知らせ • Aug 08Nutrien Ltd. Announces the Appointment of Mark Thompson as Executive Vice President, Effective August 26, 2024Nutrien Ltd. announced the appointment of Mark Thompson as Executive Vice President, effective August 26, 2024. Mr. Thompson has been with the Company since 2011, currently serving as Executive Vice President and Chief Commercial Officer. Prior to his current position he held numerous executive and senior leadership roles across the company, including Chief Strategy & Sustainability Officer, Chief Corporate Development & Strategy Officer, and Vice President of Business Development for Nutrien’s Retail business. He earned his Bachelor of Commerce (Finance) and Bachelor of Arts degrees from the University of Saskatchewan and holds the Chartered Financial Analyst (CFA) designation.
お知らせ • Jun 18Nutrien Ltd. to Report Q2, 2024 Results on Aug 07, 2024Nutrien Ltd. announced that they will report Q2, 2024 results on Aug 07, 2024
Buy Or Sell Opportunity • Jun 11Now 22% undervaluedThe stock has been flat over the last 90 days, currently trading at US$53.24. The fair value is estimated to be US$68.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.5% over the last 3 years. Earnings per share has grown by 8.6%. For the next 3 years, revenue is forecast to grow by 1.9% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.
Declared Dividend • May 12First quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 28th June 2024 Payment date: 19th July 2024 Dividend yield will be 3.7%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (125% earnings payout ratio). However, it is well covered by cash flows (37% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 39% to bring the payout ratio under control. EPS is expected to grow by 38% over the next 3 years, which should be enough to bring the dividend into a sustainable range.
お知らせ • May 10Nutrien Ltd. Approves the Election of Julie A. Lagacy as DirectorNutrien Ltd. at its annual meeting of shareholders held on May 8, 2024 approved the election of Julie A. Lagacy as Director.
Reported Earnings • May 09First quarter 2024 earnings released: EPS: US$0.32 (vs US$1.14 in 1Q 2023)First quarter 2024 results: EPS: US$0.32 (down from US$1.14 in 1Q 2023). Revenue: US$5.15b (down 13% from 1Q 2023). Net income: US$158.0m (down 72% from 1Q 2023). Profit margin: 3.1% (down from 9.7% in 1Q 2023). Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
お知らせ • May 09Nutrien Ltd. Declares Quarterly Dividend, Payable on July 19, 2024Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.54 per share payable on July 19, 2024, to shareholders of record on June 28, 2024.
お知らせ • Apr 15Nutrien Reportedly Seeks an Exit from its Retail Assets in Argentina, Chile and UruguayCanadian fertiliser giant Nutrien Ltd. (TSX:NTR) is seeking an exit from its retail assets in Argentina, Chile and Uruguay, Reuters reported citing a statement from the company. The move is said to be aimed at simplifying the company’s business and concentrating on key markets, such as Brazil.
お知らせ • Apr 11Nutrien Ltd. to Report Q1, 2024 Results on May 08, 2024Nutrien Ltd. announced that they will report Q1, 2024 results After-Market on May 08, 2024
Upcoming Dividend • Mar 20Upcoming dividend of US$0.54 per shareEligible shareholders must have bought the stock before 27 March 2024. Payment date: 11 April 2024. Payout ratio is on the higher end at 84%, however this is supported by cash flows. Trailing yield: 4.1%. Lower than top quartile of British dividend payers (6.2%). Higher than average of industry peers (3.0%).
Declared Dividend • Mar 04Fourth quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 27th March 2024 Payment date: 11th April 2024 Dividend yield will be 4.0%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (84% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 25% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Feb 24Nutrien Ltd., Annual General Meeting, May 08, 2024Nutrien Ltd., Annual General Meeting, May 08, 2024.
お知らせ • Feb 22Nutrien Ltd. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023Nutrien Ltd. reported impairment charges for the fourth quarter ended December 31, 2023. For the quarter, the company recognized a $76 million non-cash impairment in Nitrogen segment relating to Trinidad property, plant and equipment due to a new natural gas contract and the resulting outlook for higher expected natural gas costs and constrained near-term availability.
New Risk • Feb 22New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (41% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.5% net profit margin).
Reported Earnings • Feb 22Full year 2023 earnings released: EPS: US$2.53 (vs US$14.23 in FY 2022)Full year 2023 results: EPS: US$2.53 (down from US$14.23 in FY 2022). Revenue: US$28.1b (down 24% from FY 2022). Net income: US$1.26b (down 84% from FY 2022). Profit margin: 4.5% (down from 21% in FY 2022). Revenue is forecast to stay flat during the next 3 years compared to a 4.1% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
お知らせ • Feb 22+ 1 more updateNutrien Ltd. Revises Sales Volume Guidance for the Year 2024Nutrien Ltd. revised sales volume guidance for the year 2024. For the year, the company expects Potash sales volume guidance of 13.0 to 13.8 million tonnes assumes demand growth in offshore markets and a return to more normal Canpotex port operations in 2024. In North America, The company expects increased first quarter sales volumes compared to the prior year due to strong customer engagement to refill depleted inventories. Nitrogen sales volume guidance of 10.6 to 11.2 million tonnes assumes higher operating rates at US and Trinidad plants compared to 2023. Phosphate sales volume guidance of 2.6 to 2.8 million tonnes assumes improved operating rates compared to the prior year.
お知らせ • Jan 24Nutrien Ltd. to Report Q4, 2023 Results on Feb 21, 2024Nutrien Ltd. announced that they will report Q4, 2023 results After-Market on Feb 21, 2024
Upcoming Dividend • Dec 21Upcoming dividend of US$0.53 per share at 3.8% yieldEligible shareholders must have bought the stock before 28 December 2023. Payment date: 12 January 2024. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 3.8%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.9%).
Reported Earnings • Nov 02Third quarter 2023 earnings released: EPS: US$0.15 (vs US$2.95 in 3Q 2022)Third quarter 2023 results: EPS: US$0.15 (down from US$2.95 in 3Q 2022). Revenue: US$5.37b (down 33% from 3Q 2022). Net income: US$75.0m (down 95% from 3Q 2022). Profit margin: 1.4% (down from 20% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
お知らせ • Nov 02Nutrien Ltd. Declares Quarterly Dividend, Payable on January 12, 2024Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.53 per share payable on January 12, 2024, to shareholders of record on December 29, 2023.
お知らせ • Oct 06Nutrien Ltd. to Report Q3, 2023 Results on Nov 01, 2023Nutrien Ltd. announced that they will report Q3, 2023 results After-Market on Nov 01, 2023
Upcoming Dividend • Sep 21Upcoming dividend of US$0.53 per share at 3.4% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 13 October 2023. Payout ratio is a comfortable 28% and this is well supported by cash flows. Trailing yield: 3.4%. Lower than top quartile of British dividend payers (6.2%). Higher than average of industry peers (3.0%).
New Risk • Aug 04New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 11% Last year net profit margin: 20% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 14% per year for the foreseeable future. Minor Risks High level of debt (46% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (11% net profit margin).
Reported Earnings • Aug 03Second quarter 2023 earnings released: EPS: US$0.89 (vs US$6.53 in 2Q 2022)Second quarter 2023 results: EPS: US$0.89 (down from US$6.53 in 2Q 2022). Revenue: US$11.4b (down 20% from 2Q 2022). Net income: US$440.0m (down 88% from 2Q 2022). Profit margin: 3.9% (down from 25% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Revenue is expected to fall by 2.5% p.a. on average during the next 3 years compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Aug 03Nutrien Ltd. Declares Quarterly Dividend, Payable on October 13, 2023Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.53 per share payable on October 13, 2023, to shareholders of record on September 29, 2023.
お知らせ • Jun 29Nutrien Ltd. to Report Q2, 2023 Results on Aug 02, 2023Nutrien Ltd. announced that they will report Q2, 2023 results After-Market on Aug 02, 2023
Upcoming Dividend • Jun 22Upcoming dividend of US$0.53 per share at 3.5% yieldEligible shareholders must have bought the stock before 29 June 2023. Payment date: 14 July 2023. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 3.5%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.8%).
